Antiangiogenic Other
| Cat. No. | Product Name / Activity |
|---|---|
| 5121 | 3PO |
| PFKFB3 inhibitor; antiangiogenic | |
| 5617 | AZD 1480 |
| Potent and selective JAK2 inhibitor; antiangiogenic | |
| 5029 | CHC |
| Monocarboxylic acid transport (MCT) inhibitor; displays anti-angiogenic activities | |
| 1629 | Herbimycin A |
| Antiangiogenic. Inhibits Src family kinases and Hsp90 | |
| 5981 | Itraconazole |
| SMO antagonist; antiangiogenic | |
| 5260 | KG 5 |
| Antiangiogenic; PDGFRβ, B-Raf, c-Raf, FLT3 and KIT inhibitor | |
| 4664 | Obtustatin |
| Potent and selective α1β1 inhibitor; antiangiogenic | |
| 2710 | OGT 2115 |
| Antiangiogenic. Heparanase inhibitor | |
| 2954 | PX 12 |
| Thioredoxin-1 inhibitor; attenuates expression of HIF-1α | |
| 1418 | Resveratrol |
| Cyclooxygenase inhbitor | |
| 0652 | Thalidomide |
| Antiangiogenic; also inhibits TNF-α synthesis | |
| 1098 | Tranilast |
| Antiangiogenic |
Angiogenesis in Cancer Life Science Poster
Our Angiogenesis in Cancer poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.
Request copyDownload PDF